Microsoft Teams Migration for Biopharmaceutical Company

This case study details the migration of a global biopharmaceutical company's voice infrastructure to Microsoft Teams. The company operates in nearly 40 countries and faced challenges with its existing systems, which included analog and legacy digital solutions. The transition was prompted by issues with their US provider, which affected compliance with FDA regulations regarding phone number availability. BCM One was engaged to provide Pure IP Enterprise Voice for Microsoft Teams, integrating with the company's existing UCaaS infrastructure. The project involved careful planning and coordination, especially during the COVID-19 pandemic, which accelerated the transition. The migration was completed ahead of schedule, with a focus on essential functionalities first. The consolidation of telephony services resulted in a 25% cost savings for the company. Additionally, BCM One facilitated HIPAA-compliant call recording through a reliable provider, further enhancing the company's operational efficiency while adhering to regulatory requirements.